With management describing the firm as a seed-stage medical device company, the Ananya Health team are structured around building a platform having the capacity to freeze abnormal cells in the cervix before they become malignant cervical cancer. The firm's cryoablation platform generates standard of care outcomes without consumable cryogen gas, and is specifically designed to overcome the barriers to cancer prevention at the local, community health level.
